Seguir
Vivek Verma
Vivek Verma
Verma Radiation Oncology Consulting (VROC)
No hay ninguna dirección de correo electrónico verificada.
Título
Citado por
Citado por
Año
Pembrolizumab with or without radiotherapy for metastatic non-small-cell lung cancer: a pooled analysis of two randomised trials
WSME Theelen, D Chen, V Verma, BP Hobbs, HMU Peulen, JGJV Aerts, ...
The Lancet Respiratory Medicine 9 (5), 467-475, 2021
3442021
A systematic review of the cost and cost-effectiveness studies of immune checkpoint inhibitors
V Verma, T Sprave, W Haque, CB Simone, JY Chang, JW Welsh, ...
Journal for immunotherapy of cancer 6, 1-15, 2018
2762018
Response rates and pathologic complete response by breast cancer molecular subtype following neoadjuvant chemotherapy
W Haque, V Verma, S Hatch, V Suzanne Klimberg, E Brian Butler, BS Teh
Breast cancer research and treatment 170, 559-567, 2018
2662018
A systematic review of the cost and cost‐effectiveness studies of proton radiotherapy
V Verma, MV Mishra, MP Mehta
Cancer 122 (10), 1483-1501, 2016
2202016
Randomized phase IIB trial of proton beam therapy versus intensity-modulated radiation therapy for locally advanced esophageal cancer
SH Lin, BP Hobbs, V Verma, RS Tidwell, GL Smith, X Lei, EM Corsini, ...
Journal of Clinical Oncology 38 (14), 1569, 2020
2022020
Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified …
JY Chang, RJ Mehran, L Feng, V Verma, Z Liao, JW Welsh, SH Lin, ...
The Lancet Oncology 22 (10), 1448-1457, 2021
1962021
Randomized phase II trial evaluating pain response in patients with spinal metastases following stereotactic body radiotherapy versus three-dimensional conformal radiotherapy
T Sprave, V Verma, R Förster, I Schlampp, T Bruckner, T Bostel, SE Welte, ...
Radiotherapy and Oncology 128 (2), 274-282, 2018
1942018
Pembrolizumab with or without radiation therapy for metastatic non-small cell lung cancer: a randomized phase I/II trial
J Welsh, H Menon, D Chen, V Verma, C Tang, M Altan, K Hess, ...
Journal for immunotherapy of cancer 8 (2), 2020
1742020
Evaluation of first-line radiosurgery vs whole-brain radiotherapy for small cell lung cancer brain metastases: the FIRE-SCLC cohort study
CG Rusthoven, M Yamamoto, D Bernhardt, DE Smith, D Gao, T Serizawa, ...
JAMA oncology 6 (7), 1028-1037, 2020
1522020
Proton beam radiotherapy and concurrent chemotherapy for unresectable stage III non–small cell lung cancer: final results of a phase 2 study
JY Chang, V Verma, M Li, W Zhang, R Komaki, C Lu, PK Allen, Z Liao, ...
JAMA oncology 3 (8), e172032-e172032, 2017
1412017
A systematic review and meta-analysis of cancer patients affected by a novel coronavirus
BP Venkatesulu, VT Chandrasekar, P Girdhar, P Advani, A Sharma, ...
JNCI cancer spectrum 5 (2), pkaa102, 2021
1372021
Hypomethylating agents in relapsed and refractory AML: outcomes and their predictors in a large international patient cohort
M Stahl, M DeVeaux, P Montesinos, R Itzykson, EK Ritchie, MA Sekeres, ...
Blood advances 2 (8), 923-932, 2018
1322018
Role of radiation therapy in modulation of the tumor stroma and microenvironment
H Menon, R Ramapriyan, TR Cushman, V Verma, HH Kim, C Atalar, ...
Frontiers in immunology 10, 432757, 2019
1312019
Randomized Trial of First-Line Tyrosine Kinase Inhibitor With or Without Radiotherapy for Synchronous Oligometastatic EGFR-Mutated Non-Small Cell Lung Cancer
XS Wang, YF Bai, V Verma, RL Yu, W Tian, R Ao, Y Deng, XQ Zhu, H Liu, ...
JNCI: Journal of the National Cancer Institute 115 (6), 742-748, 2023
1272023
The use of immunosuppressive therapy in MDS: clinical outcomes and their predictors in a large international patient cohort
M Stahl, M DeVeaux, T De Witte, J Neukirchen, MA Sekeres, AM Brunner, ...
Blood advances 2 (14), 1765-1772, 2018
1202018
Radiotherapy workflow and protection procedures during the Coronavirus Disease 2019 (COVID-19) outbreak: Experience of the Hubei Cancer Hospital in Wuhan, China
W Wei, D Zheng, Y Lei, S Wu, V Verma, Y Liu, X Wei, J Bi, D Hu, G Han
Radiotherapy and Oncology 148, 203-210, 2020
1182020
The rise of radiomics and implications for oncologic management
V Verma, CB Simone, S Krishnan, SH Lin, J Yang, SM Hahn
JNCI: Journal of the National Cancer Institute 109 (7), djx055, 2017
1182017
Quality of life and patient-reported outcomes following proton radiation therapy: a systematic review
V Verma, CB Simone, MV Mishra
JNCI: Journal of the National Cancer Institute 110 (4), 341-353, 2018
1072018
Influence of low-dose radiation on abscopal responses in patients receiving high-dose radiation and immunotherapy
H Menon, D Chen, R Ramapriyan, V Verma, HB Barsoumian, ...
Journal for immunotherapy of cancer 7, 1-9, 2019
1052019
Phase II trial of ipilimumab with stereotactic radiation therapy for metastatic disease: outcomes, toxicities, and low-dose radiation–related abscopal responses
JW Welsh, C Tang, P De Groot, A Naing, KR Hess, JV Heymach, ...
Cancer immunology research 7 (12), 1903-1909, 2019
982019
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20